Showing all published months. Partner preview tables include up to 5 countries.
USD value by month, all available partner countries combined
Free partner preview shows up to 5 countries.
Total value across the selected data period
| Partner | Value | Share |
|---|---|---|
| UAE | $32.1M | 48.8% |
| Japan | $25.1M | 38.1% |
| Germany | $3.9M | 5.8% |
| Netherlands | $2.4M | 3.7% |
| United States | $1.4M | 2.1% |
Availability is confirmed when the API response loads.
| Partner | Value | Share |
|---|---|---|
| Japan | $3.1M | 82.9% |
| UAE | $590.3K | 15.9% |
| United States | $47.6K | 1.3% |
| Year | Export value |
|---|---|
| 2021 | $9.5M |
| 2022 | $9.2M |
| 2023 | $6.6M |
| 2024 | $4.5M |
| 2025 | $7M |
| 2026 | $29.1M |
China customs reports HS 300349 at the 8-digit level. 1 subheading is published under it, and export values for each are available on request.
Public data shows up to 5 partner countries. Request all available countries, years, quantity fields, or HS8 detail in CSV.
HS 300349 is also written 3003.49. Values are in USD; the public series does not report tonnes or kg. Product scope: Bulk alkaloid-based medicinal preparations, excluding those with hormones, steroids, antibiotics, ephedrine, or pseudoephedrine, shipped in non-retail packaging for further pharmaceutical manufacturing. The public page shows monthly export partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Alkaloids medicine (HS 300349) Export Data." https://chinadata.live/china-trade/hs/300349/
HS 300349 is also written 3003.49. Values are in USD; the public series does not report tonnes or kg. Product scope: Bulk alkaloid-based medicinal preparations, excluding those with hormones, steroids, antibiotics, ephedrine, or pseudoephedrine, shipped in non-retail packaging for further pharmaceutical manufacturing. The public page shows monthly export partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Alkaloids medicine (HS 300349) Export Data." https://chinadata.live/china-trade/hs/300349/
China exported $33.0M of alkaloids medicine in the twelve months to August 2026, averaging $2.7M per month, based on official China customs statistics (HS 300349).
Bulk alkaloid-based medicinal preparations, excluding those with hormones, steroids, antibiotics, ephedrine, or pseudoephedrine, shipped in non-retail packaging for further pharmaceutical manufacturing.
UAE, Japan and Germany together account for 93% of the published total, out of 4 trading partners on record.
Annual exports declined by 26% between 2021 and 2025, from $9.5M to $7.0M.
Figures come from official China General Administration of Customs (GACC) statistics, published monthly. ChinaData cleans partner names, periods and values so the series is ready for analysis. Partner-level rows for every month, including HS8 detail, are available on request.